High antithrombin III levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypass.
D000368:Aged; D000990:Antithrombin III / Q000008:administration & dosage*; D002315:Cardiopulmonary Bypass; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D007432:Intraoperative Period; D007962:Leukocytes / Q000187:drug effects* / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D015842:Serine Proteinase Inhibitors / Q000008:administration & dosage*
D015842:Serine Proteinase Inhibitors; D000990:Antithrombin III